Full text is available at the source.
Using light-based treatment for a rare scalp inflammation causing hair loss
Updated
Abstract
A 26-year-old man experienced significant improvement in folliculitis decalvans after 25 months of systemic photodynamic therapy.
- Folliculitis decalvans is estimated to account for approximately 10% of primary cicatricial alopecia cases.
- Dysfunctional immune activity and Staphylococcus aureus are potentially key factors in the condition.
- Systemic photodynamic therapy using ultraviolet light and porfimer sodium showed promising results as a monotherapy.
- This treatment is associated with strong antibacterial effects and minimal resistance.
- Systemic photodynamic therapy may also enhance local immune response and improve scar healing.
- Significant adverse effects from this therapy are rare when appropriate aftercare is provided.
Simplified